Biolife Solutions (BLFS) Income from Continuing Operations (2010 - 2026)
Biolife Solutions (BLFS) reported Income from Continuing Operations of 1148000.0 for Q1 2026, up 323.62% year-over-year from 271000.0 in Q1 2025, and down 67.32% quarter-over-quarter from 3513000.0 in Q4 2025.
Biolife Solutions (BLFS) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has 17 years of Income from Continuing Operations data on file, last reported at 1148000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 1148000.0, up 323.62% year-over-year; the trailing twelve-month figure through Mar 2026 was 10556000.0 (down 98.61% YoY), and the FY2025 annual result was 12130000.0, down 38.08% from the prior year.
- Income from Continuing Operations slipped to 1148000.0 in Q1 2026 per BLFS's latest filing, from 3513000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 91004000.0 in Q4 2022 and troughed at 72878000.0 in Q2 2022.
- A 5-year average of 2107764.71 and a median of 3199000.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations slumped 13159.49% in 2022, then soared 689.44% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 91004000.0 in 2022, then tumbled by 80.35% to 17886000.0 in 2023, then plunged by 97.51% to 445000.0 in 2024, then soared by 689.44% to 3513000.0 in 2025, then tumbled by 67.32% to 1148000.0 in 2026.
- Business Quant data shows BLFS's Income from Continuing Operations at 1148000.0 in Q1 2026, 3513000.0 in Q4 2025, and 621000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -17.00 Mn |
| 10 | Biolife Solutions | 1.27 Bn | 1.19 Bn | 17.50 Mn | 1.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 3.51 Mn |
| Sep 30, 2025 | 621,000.00 |
| Jun 30, 2025 | -15.84 Mn |
| Mar 31, 2025 | 271,000.00 |
| Dec 31, 2024 | 445,000.00 |
| Sep 30, 2024 | -471,000.00 |
| Jun 30, 2024 | -5.56 Mn |
| Mar 31, 2024 | -3.20 Mn |
| Dec 31, 2023 | 17.89 Mn |
| Sep 30, 2023 | -15.80 Mn |
| Jun 30, 2023 | -5.52 Mn |
| Mar 31, 2023 | -13.71 Mn |
| Dec 31, 2022 | 91.00 Mn |
| Sep 30, 2022 | -10.32 Mn |
| Jun 30, 2022 | -72.88 Mn |
| Mar 31, 2022 | -7.42 Mn |
| Dec 31, 2021 | -15.75 Mn |
| Sep 30, 2021 | 79,000.00 |
| Jun 30, 2021 | 7.88 Mn |